Testing Kit Detects Gene Variants Linked to Cystic Fibrosis
Asuragen Inc. has launched a testing kit for research use that is designed to detect pathogenic variants in the CFTR gene that cause cystic fibrosis.
Read MorePosted by Chris Wolski | Nov 12, 2021 | Molecular Diagnostic Analyzers, Respiratory Disease |
Asuragen Inc. has launched a testing kit for research use that is designed to detect pathogenic variants in the CFTR gene that cause cystic fibrosis.
Read MorePosted by Chris Wolski | Sep 3, 2021 | Disease States |
New research has uncovered a precision medicine test to identify a patient subgroup of a rare blood disorder who are more likely to respond to treatment.
Read MorePosted by Chris Wolski | Jul 2, 2021 | Diagnostic Technologies |
University of Michigan researchers have found evidence suggesting that preoperative testing is often unnecessary for low-risk surgeries.
Read MorePosted by Melanie Hamilton-Basich | Jun 22, 2021 | Digital Pathology |
Epredia has been appointed as a global distribution partner for Aiforia’s portfolio of preclinical and clinical pathology tools, including segment exclusivity for distribution in the United States.
Read MorePosted by Chris Wolski | May 12, 2021 | Covid 19 |
To identify and treat COVID-19 patients at an early stage, predictive biomarkers need to be identified; researchers have discovered one.
Read More